Biology of pediatric peripheral neuroectodermal tumors
1Molecular Genetics Section, National Cancer Institute, Bethesda, Maryland.
Cancer Metastasis Reviews
|December 1, 1991
Summary
Pediatric peripheral neuroectodermal tumors like neuroblastoma may arise from different neural crest cell stages. Retinoic acid differentiation of neuroblastoma models helps identify genes controlling growth and differentiation.
Area of Science:
- Pediatric oncology
- Developmental biology
- Cancer cell biology
Background:
- Pediatric peripheral neuroectodermal tumors (PNETs), including neuroblastoma, peripheral neuroepithelioma, and Ewing's sarcoma, are thought to originate from neural crest cells.
- These tumors may represent distinct cell lineages or arrest points during neural crest development.
- Understanding their origins is crucial for accurate classification and treatment.
Purpose of the Study:
- To review the cell and molecular biological contributions to the re-classification of pediatric PNETs.
- To examine the clinical features of these tumors.
- To explore the potential of retinoic acid-induced differentiation as a model for identifying key genes in tumor development.
Main Methods:
- Review of cell and molecular biological studies on pediatric PNETs.
- Analysis of clinical features.
- Examination of retinoic acid-induced differentiation models, particularly for neuroblastoma.
Main Results:
- Cell and molecular studies have led to a revised understanding and classification of these tumors.
- Neuroblastoma differentiation induced by retinoic acid serves as a valuable model.
- This model aids in identifying genes involved in cell growth, tumor suppression, and differentiation induction.
Conclusions:
- Pediatric PNETs likely originate from distinct neural crest cell lineages or developmental stages.
- Retinoic acid-induced differentiation of neuroblastoma is a powerful tool for uncovering genes critical to tumor biology.
- Further research into these mechanisms can inform therapeutic strategies for pediatric cancers.


